66 related articles for article (PubMed ID: 21353492)
1. Clarithromycin modulates immune responses in experimental peritonitis.
Atmatzidis S; Koutelidakis I; Chatzimavroudis G; Louis K; Pistiki A; Roditis K; Atmatzidis K; Giamarellos-Bourboulis EJ
Int J Antimicrob Agents; 2011 Apr; 37(4):347-51. PubMed ID: 21353492
[TBL] [Abstract][Full Text] [Related]
2. Clarithromycin is an effective immunomodulator in experimental pyelonephritis caused by pan-resistant Klebsiella pneumoniae.
Giamarellos-Bourboulis EJ; Tziortzioti V; Koutoukas P; Baziaka F; Raftogiannis M; Antonopoulou A; Adamis T; Sabracos L; Giamarellou H
J Antimicrob Chemother; 2006 May; 57(5):937-44. PubMed ID: 16549515
[TBL] [Abstract][Full Text] [Related]
3. Clarithromycin is an effective immunomodulator when administered late in experimental pyelonephritis by multidrug-resistant Pseudomonas aeruginosa.
Giamarellos-Bourboulis EJ; Antonopoulou A; Raftogiannis M; Koutoukas P; Tsaganos T; Tziortzioti V; Panagou C; Adamis T; Giamarellou H
BMC Infect Dis; 2006 Feb; 6():31. PubMed ID: 16504031
[TBL] [Abstract][Full Text] [Related]
4. Effect of clarithromycin in experimental empyema by multidrug-resistant Pseudomonas aeruginosa.
Tsovolou EC; Tzepi IM; Spyridaki A; Tsaganos T; Karagianni V; Menenakos E; Liakou P; Sabracos L; Zografos G; Giamarellos-Bourboulis EJ
APMIS; 2014 Jan; 122(1):68-75. PubMed ID: 23656439
[TBL] [Abstract][Full Text] [Related]
5. Clarithromycin: immunomodulatory therapy of experimental sepsis and acute pyelonephritis by Escherichia coli.
Giamarellos-Bourboulis E; Adamis T; Sabracos L; Raftogiannis M; Baziaka F; Tsaganos T; Koutoukas P; Plachouras D; Karayannacos P; Giamarellou H
Scand J Infect Dis; 2005; 37(1):48-54. PubMed ID: 15764190
[TBL] [Abstract][Full Text] [Related]
6. Clarithromycin co-administered with amikacin attenuates systemic inflammation in experimental sepsis with Escherichia coli.
Giamarellos-Bourboulis EJ; Baziaka F; Antonopoulou A; Koutoukas P; Kousoulas V; Sabracos L; Panagou C; Perrea D; Giamarellou H
Int J Antimicrob Agents; 2005 Feb; 25(2):168-72. PubMed ID: 15664488
[TBL] [Abstract][Full Text] [Related]
7. Detrimental effect of apoptosis of lymphocytes at an early time point of experimental abdominal sepsis.
Atmatzidis S; Koutelidakis IM; Chatzimavroudis G; Kotsaki A; Louis K; Pistiki A; Savva A; Antonopoulou A; Atmatzidis K; Giamarellos-Bourboulis EJ
BMC Infect Dis; 2011 Nov; 11():321. PubMed ID: 22099496
[TBL] [Abstract][Full Text] [Related]
8. Tachyplesin III and granulocyte-colony stimulating factor enhance the efficacy of tazobactam/piperacillin in a neutropenic mouse model of polymicrobial peritonitis.
Cirioni O; Ghiselli R; Kamysz W; Orlando F; Silvestri C; Mocchegiani F; Di Matteo F; Kamysz E; Riva A; Rocchi M; Saba V; Scalise G; Giacometti A
Peptides; 2008 Jan; 29(1):31-8. PubMed ID: 18068869
[TBL] [Abstract][Full Text] [Related]
9. Early apoptosis of monocytes contributes to the pathogenesis of systemic inflammatory response and of bacterial translocation in an experimental model of multiple trauma.
Efstathopoulos N; Tsaganos T; Giamarellos-Bourboulis EJ; Kaldis P; Nicolaou V; Papalois A; Koutoukas P; Papachristou G; Giamarellou H
Clin Exp Immunol; 2006 Jul; 145(1):139-46. PubMed ID: 16792684
[TBL] [Abstract][Full Text] [Related]
10. Pre-treatment with low-dose endotoxin prolongs survival from experimental lethal endotoxic shock: Benefit for lethal peritonitis by Escherichia coli.
Kopanakis K; Tzepi IM; Pistiki A; Carrer DP; Netea MG; Georgitsi M; Lymperi M; Droggiti DI; Liakakos T; Machairas A; Giamarellos-Bourboulis EJ
Cytokine; 2013 Jun; 62(3):382-8. PubMed ID: 23602853
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of the bovine antimicrobial peptide indolicidin combined with piperacillin/tazobactam in experimental rat models of polymicrobial peritonitis.
Ghiselli R; Giacometti A; Cirioni O; Mocchegiani F; Orlando F; Silvestri C; Di Matteo F; Abbruzzetti A; Scalise G; Saba V
Crit Care Med; 2008 Jan; 36(1):240-5. PubMed ID: 18090372
[TBL] [Abstract][Full Text] [Related]
12. The impact of multidrug resistance on the pathogenicity of Escherichia coli: an experimental study.
Bristianou M; Panagou C; Adamis T; Raftogiannis M; Antonopoulou A; Chrisofos M; Galani I; Kanellakopoulou K; Tsaganos T; Giamarellos-Bourboulis EJ
Int J Antimicrob Agents; 2008 Mar; 31(3):216-23. PubMed ID: 18248963
[TBL] [Abstract][Full Text] [Related]
13. Immunomodulatory effect of three-day continuous administration of clarithromycin for experimental sepsis due to multidrug-resistant Pseudomonas aeruginosa.
Baziaka F; Giamarellos-Bourboulis EJ; Raftogiannis M; Adamis T; Tziortzioti V; Sabracos L; Chrisofos M; Koutoukas P; Giamarellou H; Douzinas EE
J Chemother; 2008 Feb; 20(1):63-8. PubMed ID: 18343746
[TBL] [Abstract][Full Text] [Related]
14. [Influence of the escharectomy during stock stage on the peripheral lymphocyte apoptosis and the antigen presentation function of monocytes in peripheral blood of scalded rats].
Liu QY; Hu S; Cheng AG; Qiu F; Pu JY; Li JY; Lv Y; Zhou GY; Sheng ZY
Zhonghua Shao Shang Za Zhi; 2006 Dec; 22(6):415-8. PubMed ID: 17438684
[TBL] [Abstract][Full Text] [Related]
15. Effect of melatonin on healing of colonic anastomosis in a rat model of peritonitis.
Ozen IO; Ekingen G; Taşlipinar MY; Bukan N; Demiroğullari B; Karabulut R; Sönmez K; Başaklar AC; Kale N
Eur Surg Res; 2007; 39(2):122-7. PubMed ID: 17337888
[TBL] [Abstract][Full Text] [Related]
16. Lafutidine versus lansoprazole in combination with clarithromycin and amoxicillin for one versus two weeks for Helicobacter pylori eradication in Korea.
Kim N; Park SH; Seo GS; Lee SW; Kim JW; Lee KJ; Shin WC; Kim TN; Park MI; Park JJ; Hong SJ; Shim KN; Kim SW; Shin YW; Chang YW; Chun HJ; Lee OJ; Jeon WJ; Park CG; Cho CM; Park CH; Won SY; Lee GH; Park KS; Shin JE; Kim HU; Park JY; Chae HS; Song GA; Kim JG; Yoon BC; Seol S; Jung HC; Chung IS
Helicobacter; 2008 Dec; 13(6):542-9. PubMed ID: 19166420
[TBL] [Abstract][Full Text] [Related]
17. Experimental sepsis using Pseudomonas aeruginosa: the significance of multi-drug resistance.
Giamarellos-Bourboulis EJ; Koussoulas V; Panagou C; Adamis T; Baziaka F; Skiadas I; Perrea D; Dionyssiou-Asteriou A; Giamarellou H
Int J Antimicrob Agents; 2004 Oct; 24(4):357-61. PubMed ID: 15380261
[TBL] [Abstract][Full Text] [Related]
18. Antibiotics modulate the stimulated cytokine response to endotoxin in a human ex vivo, in vitro model.
Ziegeler S; Raddatz A; Hoff G; Buchinger H; Bauer I; Stockhausen A; Sasse H; Sandmann I; Hörsch S; Rensing H
Acta Anaesthesiol Scand; 2006 Oct; 50(9):1103-10. PubMed ID: 16939481
[TBL] [Abstract][Full Text] [Related]
19. Oleuropein: a novel immunomodulator conferring prolonged survival in experimental sepsis by Pseudomonas aeruginosa.
Giamarellos-Bourboulis EJ; Geladopoulos T; Chrisofos M; Koutoukas P; Vassiliadis J; Alexandrou I; Tsaganos T; Sabracos L; Karagianni V; Pelekanou E; Tzepi I; Kranidioti H; Koussoulas V; Giamarellou H
Shock; 2006 Oct; 26(4):410-6. PubMed ID: 16980890
[TBL] [Abstract][Full Text] [Related]
20. Immunomodulatory clarithromycin treatment of experimental sepsis and acute pyelonephritis caused by multidrug-resistant Pseudomonas aeruginosa.
Giamarellos-Bourboulis EJ; Adamis T; Laoutaris G; Sabracos L; Koussoulas V; Mouktaroudi M; Perrea D; Karayannacos PE; Giamarellou H
Antimicrob Agents Chemother; 2004 Jan; 48(1):93-9. PubMed ID: 14693524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
